neo-angin
neo-angin is a medicine authorised by Swissmedic under authorisation number 57625. The authorisation holder is Doetsch Grether AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 26 September 2006 and the authorisation is valid without a time limit. ATC code R02AA06 places the medicine in the group Throat preparations.
| Authorisation number | 57625 |
|---|---|
| Name | neo-angin |
| Full name | neo-angin, Lutschtabletten mit Zitronengeschmack |
| Authorisation holder | Doetsch Grether AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | R02AA06 |
| First authorisation | 26 September 2006 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | neo-angin, Lutschtabletten mit Zitronengeschmack | D | 26 September 2006 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 24 | Tablette(n) | R02AA06 | 12.03.3. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is neo-angin authorised in Switzerland?
Yes. neo-angin is authorised by Swissmedic under authorisation number 57625, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does neo-angin have?
neo-angin is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of neo-angin?
The authorisation holder is Doetsch Grether AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.